Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
iShares Russell 2000 ETF
IWM
$77.1B
| – | – |
-2,174
| Closed | -$249K | – |
|
3602
iShares Russell 3000 ETF
IWV
$20.5B
| – | – |
-5,800
| Closed | -$860K | – |
|
3603
iShares Global Energy ETF
IXC
$3.14B
| – | – |
-14,300
| Closed | -$242K | – |
|
3604
iShares US Energy ETF
IYE
$1.74B
| – | – |
-35,600
| Closed | -$545K | – |
|
3605
JB Hunt Transport Services
JBHT
$21.5B
| – | – |
-128,044
| Closed | -$11.8M | – |
|
3606
Johnson Controls International
JCI
$93.3B
| – | – |
-670,141
| Closed | -$18.1M | – |
|
3607
KBR
KBR
$4.44B
| – | – |
-65,000
| Closed | -$1.34M | – |
|
3608
Kelly Services Class A
KELYA
$562M
| – | – |
-36,398
| Closed | -$462K | – |
|
3609
Kirby Corp
KEX
$7.29B
| – | – |
-156,199
| Closed | -$6.79M | – |
|
3610
Keysight
KEYS
$63.8B
| – | – |
-441,900
| Closed | -$37M | – |
|
3611
KLX Energy Services
KLXE
$26.9M
| – | – |
-84,219
| Closed | -$295K | – |
|
3612
Kinsale Capital Group
KNSL
$7.74B
| – | – |
-7,800
| Closed | -$815K | – |
|
3613
Coca-Cola
KO
$378B
| – | – |
-5,718,518
| Closed | -$253M | – |
|
3614
Kodiak Sciences
KOD
$5.92B
| – | – |
-55,359
| Closed | -$2.64M | – |
|
3615
Koppers
KOP
$837M
| – | – |
-65,300
| Closed | -$808K | – |
|
3616
Kosmos Energy
KOS
$1.6B
| – | – |
-197,938
| Closed | -$177K | – |
|
3617
Kornit Digital
KRNT
$780M
| – | – |
-121,295
| Closed | -$3.02M | – |
|
3618
Kimbell Royalty Partners
KRP
$1.53B
| – | – |
-145,478
| Closed | -$848K | – |
|
3619
Kura Oncology
KURA
$936M
| – | – |
-85,271
| Closed | -$848K | – |
|
3620
Lithia Motors
LAD
$6.35B
| – | – |
-33,800
| Closed | -$2.77M | – |
|
3621
Liberty Energy
LBRT
$3.08B
| – | – |
-31,800
| Closed | -$86K | – |
|
3622
Leidos
LDOS
$15B
| – | – |
-452,750
| Closed | -$41.5M | – |
|
3623
Levi Strauss
LEVI
$7.33B
| – | – |
-386,778
| Closed | -$4.81M | – |
|
3624
Labcorp
LH
$25.5B
| – | – |
-109,653
| Closed | -$11.9M | – |
|
3625
Global X Lithium & Battery Tech ETF
LIT
$1.44B
| – | – |
-10,000
| Closed | -$217K | – |
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.